{
    "title": "[Nicorandil-associated anal ulceration].",
    "doc_id": "17072194",
    "writer": "Rival AL",
    "year": "2006",
    "summary": "BACKGROUND: Nicorandil is a potassium-channel activator used in the treatment of angina pectoris. The first cases of anal ulcerations induced by nicorandil were published in 2002. CASE REPORT: A 71-year-old man presented with a 2-year history of anal ulcerations occ â€¦",
    "abstract": "Background:\n        \n      \n      Nicorandil is a potassium-channel activator used in the treatment of angina pectoris. The first cases of anal ulcerations induced by nicorandil were published in 2002.\n    \n\n\n          Case report:\n        \n      \n      A 71-year-old man presented with a 2-year history of anal ulcerations occurring within a few months of initiation of treatment with Nicorandil. Histological tests on a biopsy sample showed granulation tissue with non-specific chronic inflammation. Nicorandil was stopped and this resulted in complete healing of the ulcers after three months.\n    \n\n\n          Discussion:\n        \n      \n      Nicorandil can induce chronic and extensive anal ulcerations. The pathogenesis is unknown. Patients are usually treated with high doses of nicorandil. Dermatologists should be aware of this rare side-effect which heals after withdrawal of the drug.",
    "link": "https://pubmed.ncbi.nlm.nih.gov/17072194/"
}